Discontinuation report ABIRATERONE
| Report ID | 257853 |
| Drug Identification Number | 02525372 |
| Brand name | ABIRATERONE |
| Common or Proper name | Common or Proper name |
| Company Name | JAMP PHARMA CORPORATION |
| Market Status | APPROVED |
| Active Ingredient(s) | ABIRATERONE ACETATE |
| Strength(s) | 250MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | Packaging size |
| ATC code | L02BX |
| ATC description | HORMONE ANTAGONISTS AND RELATED AGENTS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2023-01-01 |
| Actual discontinuation date | |
| Remaining supply date | |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-12-03 | French | Compare |
| v1 | 2025-12-03 | English | Compare |
Showing 1 to 2 of 2